CDKN1A and neoplasm: To investigate a potential association between the loss of CDK1 protein and reduction of p21, here, we have conducted co-immunoprecipitation assays using an anti-CDK1 antibody to investigate whether these two proteins could be associated in tumor cells with high vs. low brachyury levels.